Splenic Rupture: Rare Case with Factor XIII & VII Deficiencies

A rare and potentially life-threatening complication – spontaneous splenic rupture – has been reported in a patient with combined congenital deficiencies in two blood clotting factors, Factor XIII and Factor VII. This case, detailed in a recent report, underscores the importance of considering underlying coagulation disorders in individuals presenting with sudden abdominal pain, even in the absence of obvious trauma.

Understanding Spontaneous Splenic Rupture

The spleen, an organ located in the upper left abdomen, plays a vital role in filtering blood and supporting the immune system. Spontaneous splenic rupture (SSR) occurs when the spleen tears without any significant external injury. This is a medical emergency, as it can lead to internal bleeding, and shock. While relatively uncommon, SSR is often associated with underlying conditions that weaken the spleen or impair blood clotting.

Factor XIII is a crucial component of the blood coagulation cascade, responsible for stabilizing the fibrin clot that stops bleeding. A deficiency in Factor XIII, whether congenital (inherited) or acquired, can lead to excessive bleeding and a heightened risk of spontaneous hemorrhage. Factor VII is another clotting factor, and its deficiency also contributes to impaired coagulation. The combination of deficiencies in both factors, as seen in this case, significantly increases the risk of bleeding complications.

The Case Report: A Complex Presentation

The case report, published in Cureus, details an individual presenting with spontaneous splenic rupture in the context of these combined factor deficiencies. The report highlights the diagnostic challenges and the need for prompt intervention, including surgical removal of the spleen (splenectomy) and replacement of Factor XIII to control the bleeding.

Factor XIII Deficiency: A Closer Look

Factor XIII deficiency is a rare genetic disorder affecting approximately 1 in 2 million people. It can manifest with a range of symptoms, including simple bruising, prolonged bleeding from cuts, and, in severe cases, spontaneous bleeding into joints or organs. Research indicates that spontaneous splenic rupture is a recognized, though infrequent, complication of this condition. Acquired Factor XIII deficiency, while even rarer, has also been linked to spontaneous splenic rupture, as noted in a case report published in Clin Case Rep. This acquired form can occur in association with certain medical conditions or medications.

Diagnostic Challenges and the Importance of Coagulation Testing

Diagnosing Factor XIII deficiency can be challenging because routine coagulation tests often appear normal. The deficiency specifically affects the final stage of clot formation, and standard tests may not detect this subtle defect. Suspicion for Factor XIII deficiency should be raised in individuals with unexplained bleeding, particularly those with a family history of bleeding disorders. Specialized tests are required to accurately assess Factor XIII activity. The case report emphasizes the necessity of considering coagulation disorders in the differential diagnosis of atraumatic splenic rupture.

What Does This Indicate for Patients?

This case report doesn’t suggest an increased risk of spontaneous splenic rupture for the general population. However, it serves as a critical reminder for clinicians to consider rare coagulation disorders in patients presenting with spontaneous bleeding or splenic rupture, even if initial coagulation tests are unremarkable. For individuals already diagnosed with Factor XIII or Factor VII deficiency, it underscores the importance of careful monitoring and proactive management to minimize the risk of bleeding complications.

Public Health Implications and Future Directions

Given the rarity of both Factor XIII deficiency and spontaneous splenic rupture, large-scale population surveillance is not currently in place. However, increased awareness among healthcare professionals is crucial for timely diagnosis and appropriate management. Further research is needed to better understand the underlying mechanisms linking Factor XIII deficiency to splenic rupture and to develop strategies for preventing this life-threatening complication. The report highlights the importance of a multidisciplinary approach, involving hematologists, surgeons, and radiologists, in the care of patients with these complex conditions.

Looking Ahead: Continued case reporting and collaborative research efforts will be essential to refine diagnostic algorithms and optimize treatment strategies for patients with Factor XIII deficiency and other rare coagulation disorders. Clinicians should maintain a high index of suspicion for these conditions in individuals with unexplained bleeding or spontaneous splenic rupture, and timely intervention remains critical for improving patient outcomes.